Skip to main content
SpringerLink
Log in

Endocrine Heart Diseases

  • Chapter
  • First Online:
Cardiac Drug Therapy

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 3372 Accesses

Abstract

Endocrine disorders are known to cause cardiovascular disturbances that have clinical implications. Acromegaly causes enlargement of the heart, premature coronary artery disease (CAD), heart failure, hypertension, intraventricular conduction defects, and cardiac arrhythmias may require management by a cardiologist. Mild hypertension occurs in more than 50 % of patients. Rarely acromegalic cardiomyopathy occurs. The defect in the myocardium causes arrhythmias, which weaken the myocardial force that leads to heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • ACCORD Risk-Factor Control in Type 2 Diabetes the ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.

    Article  Google Scholar 

  • ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010;362:1563–74.

    Article  Google Scholar 

  • ACCORD Study Group The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.

    Article  Google Scholar 

  • Adler JT, Meyer-Rochow GY, Chen H, et al. Pheochromocytoma: current approaches and future directions. Oncologist. 2008;13:779–93.

    Article  PubMed  Google Scholar 

  • Andrews MA, O’Malley PG. Diabetes overtreatment in elderly individuals: risky business in need of better management. JAMA. 2014;311(22):2326–7.

    Article  PubMed  Google Scholar 

  • Biondi B, Palmieri EA, Lombardi G, et al. Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab. 2002;87:968–74.

    Article  CAS  PubMed  Google Scholar 

  • Bravo EL. Pheochromocytoma. Curr Ther Endocrinol Metab. 1997;6:195–7.

    CAS  PubMed  Google Scholar 

  • Castillo JG, Filsoufi F, Rahmanian PB, et al. Early and late results of valvular surgery for carcinoid heart disease. J Am Coll Cardiol. 2008;51:1507–9.

    Article  PubMed  Google Scholar 

  • Choi YH, Chung JH, Bae SW, et al. Severe coronary artery spasm can be associated with hyperthyroidism. Coronary Artery Dis. 2005;16:135–9.

    Article  Google Scholar 

  • Connolly HM, Nishimura RA, Smith HC, et al. Outcome of cardiac surgery for carcinoid heart disease. J Am Coll Cardiol. 1995;25:410–6.

    Article  CAS  PubMed  Google Scholar 

  • Connolly HM, Schaff HV, Mullany CJ, et al. Surgical management of left-sided carcinoid heart disease. Circulation. 2001;104:I36–40.

    Article  CAS  PubMed  Google Scholar 

  • Demers LM, Spencer CA. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13:3–126.

    Article  PubMed  Google Scholar 

  • Dorr M, Wolff B, Robinson DM, et al. The association of thyroid function with cardiac mass and left ventricular hypertrophy. J Clin Endocrinol Metab. 2005;90:673–7.

    Article  PubMed  Google Scholar 

  • DREAM Trial Investigators. Effect of ramipril on the incidence of diabetes. N Engl J Med. 2006;355:1551–62. DREAM.

    Article  Google Scholar 

  • Fiebrich H-B, Brouwers AH, Kerstens MN. 6-[F-18]Fluoro-L-Dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with 123I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. J Clin Endocrinol Metab. 2009;94:3922–30.

    Article  CAS  PubMed  Google Scholar 

  • Grosser T, Fries S, Lawson JA, et al. Drug resistance and pseudoresistance an unintended consequence of enteric coating aspirin. Circulation. 2013;127:377–85.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34.

    Article  CAS  PubMed  Google Scholar 

  • Hanley AJ, Zinman B, Sheridan P, et al. Effect of rosiglitazone and ramipril on b-cell function in people with impaired glucose tolerance or impaired fasting glucose. Diab Care. 2010;33:608–13.

    Article  CAS  Google Scholar 

  • Kanto JH. Current status of labetalol, the first alpha- and beta-blocking agent. Int J Clin Pharmacol Ther Toxicol. 1985;23:617–28.

    CAS  PubMed  Google Scholar 

  • Khan MG. Clinical trials. In: Cardiac drug therapy. Philadelphia, PA: WB Saunders/Elsevier; 2003. p. 502.

    Google Scholar 

  • Khan MG. Hypertension. In: Heart disease diagnosis and therapy, 2nd ed. New York: Humana Press/Springer; 2005. p. 340.

    Google Scholar 

  • Khan MG. Hypertension. In: Encyclopedia of heart diseases. New York: Springer; 2011. p. 556.

    Google Scholar 

  • Kinney MA, Narr BJ, Warner MA. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth. 2002;16:359–69.

    Article  PubMed  Google Scholar 

  • Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116:1725–35.

    Article  PubMed  Google Scholar 

  • Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501–9.

    Article  CAS  PubMed  Google Scholar 

  • Lehmann HU, Hochrein H, Witt E, et al. Hemodynamic effects of calcium antagonists: review. Hypertension. 1983;5:II66–73.

    Article  CAS  PubMed  Google Scholar 

  • Mannelli M. Management and treatment of pheochromocytomas and paragangliomas. Ann N Y Acad Sci. 2006;1073:405–16.

    Article  PubMed  Google Scholar 

  • Murphy MB, Lewis PJ, Kohner E, et al. Glucose intolerance in hypertensive patients treated with diuretics: a fourteen-year follow up. Lancet. 1982;2:1293–5.

    Article  CAS  PubMed  Google Scholar 

  • Nathan DM. Navigating the choices for diabetes prevention. NEJM. 2010;362:1533–5.

    Article  CAS  PubMed  Google Scholar 

  • Procopiou M, Finney H, Akker SA, et al. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors. Eur J Endocrinol. 2009;161:131–40.

    Article  CAS  PubMed  Google Scholar 

  • Proye C, Thevenin D, Cecat P, et al. Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients. Surgery. 1989;106:1149–54.

    CAS  PubMed  Google Scholar 

  • RECORD Study Team, Home PD, Pocock SJ, Beck-Nielsen H, et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes a multicentre, randomised, open-label trial. Lancet. 2009;373:2125–35.

    Article  CAS  PubMed  Google Scholar 

  • Rodondi N, Aujesky D, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med. 2006;119:541–51.

    Article  PubMed  Google Scholar 

  • Ross DS. Radioiodine therapy for hyperthyroidism. N Engl J Med. 2011;364:542–50.

    Article  CAS  PubMed  Google Scholar 

  • Roumie CL, Greevy RA, Carlos G, Grijalva CG, et al. Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes. JAMA. 2014;311(22):2288–96.

    Article  PubMed  Google Scholar 

  • Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228–38.

    Article  CAS  PubMed  Google Scholar 

  • The ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.

    Article  PubMed Central  Google Scholar 

  • UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. BMJ. 1998;317:713–20.

    Article  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Ottawa The Ottawa Hospital, Ottawa, ON, Canada

    M. Gabriel Khan MD, FRCPC, FRCP (London), FACC

Authors
  1. M. Gabriel Khan MD, FRCPC, FRCP (London), FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Khan, M.G. (2015). Endocrine Heart Diseases. In: Cardiac Drug Therapy. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-962-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-962-4_18

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-961-7

  • Online ISBN: 978-1-61779-962-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation